Teddi Mellencamp mencari obat penurun berat badan di tengah perjuangan melawan kanker stadium 4

Teddi Mellencamp, mantan bintang Real Housewives of Beverly Hills, mengungkapkan dalam podcast-nya bahwa ia memohon kepada dokternya untuk diberikan obat penurun berat badan GLP-1 saat berjuang melawan kanker. Berat badannya bertambah akibat steroid, namun permintaannya ditolak. Sambil bercanda mengenai ironi tersebut, ia melontarkan komentar jenaka tentang menjalani hidup terbaiknya tanpa bantuan obat tersebut.

Tunggu dulu—Teddi Mellencamp baru saja mengungkapkan cerita jujur dalam podcast 'Two Ts In A Pod'. 😲 Bintang reality show ini mengakui bahwa ia meminta GLP-1 kepada dokternya setelah steroid menyebabkan kenaikan berat badan selama perjuangannya melawan melanoma stadium 4. Namun, dokternya menolak, yang membuatnya merasa frustrasi dengan jenaka: 'Anda menyuruh saya untuk menjalani hidup terbaik saya... tapi di mana GLP-1 saya?' 👀

Artikel Terkait

Serena Williams, fit and transformed, poses athletically with tennis racket against Super Bowl ad for Zepbound weight loss drug.
Gambar dihasilkan oleh AI

Serena Williams appears in Super Bowl ad for weight loss medication

Dilaporkan oleh AI Gambar dihasilkan oleh AI

Serena Williams is set to feature in a Super Bowl commercial promoting the telehealth firm Ro and its GLP-1 weight loss medication Zepbound. The 44-year-old tennis legend discusses her body transformation, having lost up to 15.4kg since starting the treatment. The ad comes amid ongoing speculation about a potential return to professional tennis.

Former tennis star Andy Roddick has voiced support for Serena Williams' use of GLP-1 medication in her weight-loss efforts, suggesting it could aid a potential return to the court. Williams has shared how the treatment improved her health, while speculation grows following her inclusion in the anti-doping pool and practice sessions with younger players. Roddick emphasized the benefits for injury prevention during training.

Dilaporkan oleh AI

Three Cochrane reviews commissioned by the World Health Organization evaluate GLP-1 receptor agonists like tirzepatide, semaglutide, and liraglutide for weight loss in people with obesity. The drugs show substantial weight reduction compared to placebo, but researchers note limitations in long-term data and industry funding influences. Side effects such as nausea are common, raising questions about broader access and safety.

A new study from the University of Gothenburg shows that tirzepatide, the active ingredient in the diabetes and weight loss drug Mounjaro, reduces alcohol intake and relapse-like behaviors in rats and mice. This builds on prior research on semaglutide in Ozempic and Wegovy, which curbs alcohol consumption in humans. Researchers hope for similar effects in patients with alcohol dependence.

Dilaporkan oleh AI

Silicon Valley startup Twin Health uses AI and wearable sensors as an alternative to expensive GLP-1 drugs for weight management. Retired firefighter Rodney Buckley lost 100 pounds in under a year through the program. His experience highlights a shift toward personalized health tech for chronic conditions.

Best-selling author Jane Fallon, the longtime partner of comedian Ricky Gervais, has shared that she was diagnosed with early-stage breast cancer following a routine mammogram. She described the situation as challenging but emphasized the excellent prognosis and her upcoming surgery. Fallon made the announcement on social media to explain her recent quiet period.

Dilaporkan oleh AI

Bunnie XO has shared intimate details about her open relationship with husband Jelly Roll in her memoir Stripped Down: Unfiltered and Unapologetic. The book reveals a past affair that tested their bond, while recent interviews highlight positive changes from his weight loss. Jelly Roll has praised her bravery in telling their story.

 

 

 

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak